The MIF–CD74 axis has been shown to play pivotal roles in not only initiating an oncogenic signaling pathway, but also provoking inflammatory responses, thereby promoting tumor growth and an immunosuppressive milieu [10–13]. The gene discussed is MIF; the disease is neoplasm.